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a  b  s  t  r  a  c  t
Arrabidaea  brachypoda  Bureau,  Bignoniaceae,  known  as  “cipó-una”,  is  widely  used  in  traditional  medicine
in Southeastern  and Northeastern  Brazil  for kidney  stones  and  painful  joints.  This  study  was  aimed  at
evaluating  the anti-inﬂammatory  proprieties  of  the  oleanane-type  triterpenoid  3-estearioxy-olean-
12-ene  isolated  from  the  roots  of  A. brachypoda.  Carrageenan-induced  paw  oedema,  formalin  test  and
hot plate  test  were  used  to investigate  the antiinﬂammatory  activity  of 3-estearioxy-olean-12-ene  in
animals.  We observed  that  3-estearioxy-olean-12-ene  at doses  of  5, 10 and  15  mg/kg  p.o.  demonstratednﬂammation
atural product
ain
riterpene
anti-inﬂammatory  effects,  by  reduced  (p < 0.05)  paw  oedema  induced  by carrageenan  and  by  decreased
(p  <  0.05)  licking  time  caused  by a subplantar  injection  of formalin.  In  conclusion,  3-estearioxy-olean-
12-ene, a triterpene  isolated  from  the  roots  of  A. brachypoda,  demonstrate  anti-inﬂammatory  effect  in
different  tests.  Thus,  it may  be  useful  in  the  treatment  of  inﬂammatory  disorders,  which  supports  previous
claims  of its  traditional  use.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
The biodiversity of Brazilian is broad and several native Brazil-
an plant species have a long history of use in traditional medicine.
hese traditional medicinal plants contain compounds that may
ot only exhibit a broad range of therapeutic efﬁcacy but also
e useful in modern medicine. The Brazilian Cerrado (Neotropi-
al Savanna) is one of the most biogeographically diverse regions
f the world (de Medeiros et al., 2013; Agra et al., 2008; Blatt
t al., 1998; Mendonc¸ a et al., 1998). Many of these plants are
ommonly used in traditional medicine for the treatment of
everal ailments (de Medeiros et al., 2013; Blatt et al., 1998;
endonc¸ a et al., 1998), including infectious and inﬂammatory
iseases.
∗ Corresponding author.
E-mail: marceloh.santos@ufv.br (M.H. dos Santos).
http://dx.doi.org/10.1016/j.bjp.2015.03.005
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraThe genus Arrabidaea occurs in tropical America from Mexico
to Argentina, including Brazilian Cerrado. Species from the genus
Arrabidaea have been used in traditional medicine for astringent,
antioxidant, anti-inﬂammatory, antimicrobial, antitumor and
healing purposes (Zorn et al., 2001; Bolzani et al., 2003; Leite et al.,
2006; Martin et al., 2008). The Arrabidaea brachypoda Bureau,
Bignoniaceae, known as “cipó-una”, is widely used in traditional
medicine in Southeastern and Northeastern Brazil for kidney
stones and painful joints (Alcerito et al., 2002; Rodrigues et al.,
2006). Previous study reported that ethanolic extract from A.
brachypoda roots possess signiﬁcant anti-inﬂammatory effects
in laboratory animals (da Rocha et al., 2011), supporting the
traditional use of this plant in some painful and inﬂammatory
conditions. In addition, because chemical proﬁle of A. brachypoda
roots extract is established in which ﬂavonoids and triterpenes are
the major constituents (da Rocha et al., 2011, 2014).
Based on ethnopharmacological information of the Arrabidaea
brachypoda, the aim of this work was to evaluate the anti-
inﬂammatory proprieties of 3-estearioxy-olean-12-ene (1), an
oleanane-type triterpenoid, isolated from A. brachypoda roots
ethanolic extract.
 Ltda. All rights reserved.
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1
aterial and methods
lant material
Arrabidaea brachypoda Bureau, Bignoniaceae, roots were col-
ected in Sant’Ana da Serra-João Pinheiro, Minas Gerais, Brazil. Dra.
na Maria Cristina Teixeira Braga, Department of Botanic of Fed-
ral University of Ouro Preto, identiﬁed the plant, and a voucher
pecimen was deposited at the Herbarium of Federal University of
uro Preto (voucher number 17935).
reparation of plant extract, isolation of compound and reference
rugs
To obtain the extract, the roots were dried, powdered (685 g) and
xtracted with ethanol in Soxhlet equipment for 24 h. The solvent
as removed under reduced pressure and then dried with a spray
ryer (Büchi Mini Spray Dryer B-290). The yield of the A. brachypoda
thanolic extract (AbE) was 11%. To isolate the bioactive com-
ound, AbE was chromatographed on a silica gel (230–400 mesh)
olumn (8 cm × 100 cm)  and eluted with crescent polarity mix-
ures of n-hexane/ethyl-acetate and ethyl-acetate/ethanol to give
9 fractions. These fractions were pooled into four groups according
o their similarities after the analysis using thin layer chro-
atography (TLC). Fractions 3–8 were rechromatographed on
 silica gel (230–400 mesh) column (8 cm × 100 cm)  and eluted
ith crescent polarity mixtures of n-hexane/ethyl-acetate and
thyl-acetate/ethanol to purify the triterpene 3-stearyloxy-olean-
2-ene (1). Its structure was determined using spectroscopic
echniques (Table 1). The data were compared to those veriﬁed
n a previous study investigating the chemical structure of this
ompound (Vieira-Filho et al., 2003).
3-Estearioxy-olean-12-ene (1, AbE-01) was  administered in
, 10, and 15 mg/kg doses after being suspended in vehicle (1%
odium carboxymethylcellulose suspension in distilled water).
ndomethacin (10 mg/kg, p.o.) and morphine (10 mg/kg, i.p.)  in
ehicle (saline) were used as reference drugs. Test drugs were orally
dministered in an equivalent volume of 10 ml/kg body weight of
he animal.
harmacological activities
nimals
Adult male Wistar rats weighing 180–220 g (n = 8) and adult
ale Swiss mice weighing 28–32 g (n = 10) animals, obtained from
he Central Animal Facility of the Federal University of Alfenas,
ere housed under controlled light (12:12 h light–dark cycle; lights
n at 6 am)  and temperature conditions (23 ± 1 ◦C) with access to
ater and food ad libitum. The animals were allowed to habituateo the housing facilities for at least 1 week before the experi-
ents began. All experiments were carried out between 8 am and
 pm in a quiet room and tests were performed by the same visual
bserver in a double-blind study. The experiments were conductedarmacognosia 25 (2015) 228–232 229
in accordance with the Declaration of Helsinki on the welfare of
experimental animals and with the approval of the Ethics Commit-
tee of the Federal University of Alfenas (109/2009).
Carrageenan-induced rat paw oedema
Pedal inﬂammation in rat was  produced as described previ-
ously (Vinegar et al., 1969; da Rocha et al., 2011), following an
eight o’clock fast with free access to water. Paw oedema was  mea-
sured with a plethysmometer (Model 7140, Ugo Basile, Italy). The
basal volume of the right hind paw was  determined before the
administration of any drug. After determination of the basal vol-
ume, the animals were divided into the experimental groups in
such a way that the mean volumes of the different groups were
similar. Vehicle (10 ml/kg), 3-estearioxy-olean-12-ene (doses of
5, 10, and 15 mg/kg) or indomethacin (10 mg/kg) was orally admin-
istered 1 h before the i.pl.  injection of carrageenan (1 mg, 100 l).
The paw volume was  measured 1, 2, 3 and 4 h after injection of
the inﬂammatory stimulus. The results are presented as the paw
volume (ml) variation in relation to the basal values.
Formalin test
A formalin solution (5% in 0.9% saline; 20 l/paw) was  injected
into the hind paw plantar surface (i.pl.), and the mice were indi-
vidually placed in transparent observation chambers, as previously
described (Santos and Calixto, 1997; Vilela et al., 2010). Oral
treatments (p.o.) with vehicle, indomethacin or 3-estearioxy-
olean-12-ene were given 1 h prior to formalin injection. Morphine
was administrated (i.p.) 30 min  before the test. The time spent in
licking the injected paw was  recorded and expressed as the total
licking time in the early phase (0–5 min) and late phase (20–30 min)
after formalin injection.
Hot plate test
The hot plate was  an electrically heated surface kept at a con-
stant temperature of 50.0 ± 0.5 ◦C. Mice (n = 8 per group) were
placed on the heated surface within the Plexiglas walls to con-
strain their locomotion on the plate, and the latency to a discomfort
reaction (licking of the paws or jumping) was recorded 0, 30,
60, and 120 min  after 3-estearioxy-olean-12-ene or morphine
(10 mg/kg), where upon the reaction time of 0 min  is the start of
the test. A cut-off time of 20 s was chosen to indicate complete
analgesia and to avoid tissue injury. The latencies for paw licking
or jumping were recorded for each animal (Yamamoto et al., 2002).
Statistical analysis
The data obtained were analysed using GraphPad software
programme version 6.0 and expressed as the mean ± S.E.M. Sta-
tistically signiﬁcant differences between groups were calculated
by the application of an analysis of variance (ANOVA) followed by
the Tukey test. p-Values less than 0.05 (p < 0.05) were considered
signiﬁcant.
Results
Fig. 1 shows that carrageenan induced rat paw oedema with
compared with the vehicle administration. The 3-stearyloxy-
olean-12-ene signiﬁcantly inhibited carrageenan-induced rat paw
oedema (F4,20 = 30.2; p < 0.001). The inhibitory values of oedema
at 3 h post-carrageenan treatment were 47.9, 53.1 and 50.4% for
5, 10 and 15 mg/kg of the compound, respectively. Indomethacin
(10 mg/kg) gave a percentage inhibition of 65.2% (Fig. 1). At 4 h post-
carrageenan treatment, the inhibitory values of oedema were 47.3,
55.6 and 57.1% for 5, 10 and 15 mg/kg of the compound, respec-
tively. Indomethacin (10 mg/kg) gave a percentage inhibition of
74.8% (Fig. 1).
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Table  1
NMR  spectral data of 3-(stearyloxy)olean-12-ene (AbE-01).
Carbon number AbE-01 (C) AbE-01 (H) HMBC Carbon number AbE-01 (C) AbE-01 (H) HMBC
1 37.74 1.13 and 1.61 1′ 173.55 –
2  22.69 1.64 3 2′ 34.87 2.30 1′ , 3′ ,  4′
3 80.51 4.52 1′ , 1, 2, 4, 23, 24 3′ 25.17 1.63
4  36.83 – 4′ 29.26 1.29
5  55.26 0.80 5′ 29.27 1.29
6  18.35 1.43 and 1.56 6′ 29.48 1.26
7  32.47 1.36 and 1.52 7′ 29.59 1.26
8  41.51 – 8′ 29.65 1.26
9  47.55 1.60 9′ 29.68 1.28
10  36.94 – 10′ 29.72 1.28
11  23.61 1.86 12 11′ 29.72 1.26
12  121.65 5.19 9, 11, 14, 18 12′ 29.93 1.26
13  145.16 – 13′ 29.72 1.26
14  41.69 – 14′ 29.59 1.26
15  26.24 0.96 15′ 29.48 1.26
16  27.04 2.20 28 16′ 31.93 1.26
17  32.54 – 17′ 22.69 1.26
18  47.36 1.94 12 18′ 14.12 0.88 17′ ,  16′
19 46.90 1.03 and 1.76
20  31.10 –
21  34.83 1.10 and 1.39
22  37.24 1.22 and 1.46
23  28.13 0.88 3, 4, 5, 24
24 16.82 0.88 3, 4, 5, 23
25 15.57 0.96 1, 5, 9, 10
26 16.90 0.97 7, 8, 9, 14
27 26.00 1.14 8, 13, 14, 15
t
3
s
(
p
F
5
i
t
t28  28.43 0.84 16, 17, 18, 22
29  33.35 0.88 19, 20, 21, 30
30  23.75 0.88 19, 20, 21, 29
The intrapodal administration formalin induced an nocicep-
ive behaviour of licking the paw during the test (Fig. 2B). The
-stearyloxy-olean-12-ene at doses of 5–15 mg/kg p.o. had a
igniﬁcant activity compared to the control in both the early
F5,60 = 34.3; p < 0.001; Fig. 2A) and late phases (F5,60 = 25.4;
 < 0.001, Fig. 2B) of the formalin test. The reference drug,
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ig. 1. Effects of the administration of the 3--stearyloxy-olean-12-ene (AbE-01;
,  10 and 15 mg/kg, p.o.) or indomethacin (5 mg/kg, p.o.) on rat paw oedema
nduced by intraplantar carrageenan injection (1 mg/paw). Each point represents
he mean ± S.E.M. The asterisks denote the signiﬁcance levels when compared with
he control group: *p < 0.05, **p  < <0.01, ***p < 0.001.indomethacin, suppressed only the late phase of the formalin test,
while morphine inhibited both phases of the painful stimulus.
In the hot plate test, treatment with 3-stearyloxy-olean-
12-ene at doses of 5–15 mg/kg increased the latency time as
compared to the control group at 30 (F4,39 = 6.60; p < 0.001), 60
(F4,39 = 7.36; p < 0.001) and 120 min  (F4,39 = 11.22; p < 0.001). As
expected, administration of the vehicle did not induce any antinoci-
ceptive effect. Morphine signiﬁcantly increased the latency time
(Fig. 3).
Discussion
Traditional medicine for the treatment of various diseases
is becoming more popular. Therefore, the present study was
aimed at evaluating the scientiﬁc basis for the traditional use of
A. brachypoda Bureau, Bignoniaceae, using in vivo inﬂammatory
models. The results of this investigation demonstrate that the
triterpene 3-estearioxy-olean-12-ene from A. brachypoda exerts
anti-inﬂammatory effects in animals.
For the screening of compounds possessing anti-inﬂammatory
activity, carrageenan-induced paw oedema is a model widely
employed and has frequently been used to assess the anti-
oedematogenic effect of natural products (Mendes et al., 2010).
The development of oedema induced by carrageenan is a biphasic
event. The early phase (1–2 h) is mainly mediated by histamine,
serotonin and bradykinin. The late phase is sustained by the release
of prostaglandins and nitric oxide, with a peak at 3 h, and is pro-
duced by inducible isoforms of cyclooxygenase (COX-2) and nitric
oxide synthase (iNOS) (Brito and Antonio, 1998; Seibert et al., 1994).
Previous oral treatment with this 3-stearyloxy-olean-12-ene was
effective in reducing the oedematogenic response evoked by car-
rageenan in late phase. This reduction may  be caused by inhibition
of one or more intracellular signalling pathways involved in medi-
ating the inﬂammatory response (Thomazzi et al., 2010).
The formalin test is a model that consists of two distinct
phases. The ﬁrst phase, or neurogenic phase (immediately after
C.Q. da Rocha et al. / Revista Brasileira de F
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Fig. 2. Effects of 3--stearyloxy-olean-12-ene (AbE-01) given by oral route on the
licking induced by formalin in mice. Animals were pretreated orally with vehicle,
AbE-01 (doses 5, 10, and 15 mg/kg), indomethacin (INDO; 5 mg/kg) or morphine
(MORP; 10 mg/kg) prior to formalin. The total time spent licking the hind paw
was  measured in the ﬁrst (Panel A) and second (Panel B) phases after intraplantar
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the signiﬁcance levels when compared with the control group: *p < 0.05, **p < 0.01,
***p  < 0.001.
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point represents the mean ± S.E.M. The asterisks denote the signiﬁcance levels when
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formalin injection), seems to be caused by the direct effect of
formalin on sensory C-ﬁbres. The second phase, or inﬂammatory
phase (starting approximately 20 min  after injection), is associ-
ated with the development of an inﬂammatory response and the
release of nociceptive mediators (Abbott et al., 1995; Davidson and
Carlton, 1998) A reduction of the late phase behavioural response
to an i.p.  formalin injection was  observed, demonstrating the anti-
inﬂammatory activity produced by 3-stearyloxy-olean-12-ene.
The results obtained from carrageenan-induced rat paw oedema
also conﬁrmed this effect. Similar to other substances that act
on the central nervous system (CNS), 3-stearyloxy-olean-12-ene
inhibited both phases of the formalin test in a manner similar to
that of morphine. Moreover, the results of this test are in agree-
ment with those obtained from the hot plate test, conﬁrming the
central antinociceptive effect of the compound.
Phytochemical analyses of the roots of A. brachypoda extract
indicated that the large majority of its constituents were triterpenes
(da Rocha et al., 2011). In this regard, the anti-inﬂammatory activ-
ity is a common property of many triterpenoids (Safayhi and Sailer,
1997). The anti-inﬂammatory effects of triterpenes (i.e.  oleanolic
and ursolic acids) have been attributed to various mechanisms
including: inhibition of lipoxygenase and cyclooxygenase activi-
ties, inhibition of elastase and inhibition of complement activity,
possibly through the inhibition on C3-convertase of the classical
complement pathway (Singh et al., 1992). In addition, previous
works shown that the basic carbon skeleton has no inﬂuence on
the anti-inﬂammatory activity, and the presence of a C-28 or C-
30 carboxylic group and an alcoholic group at C-28 increases the
activity in carrageenan-induces oedema (Recio et al., 1995), how-
ever, the mechanism of action of the 3-stearyloxy-olean-12-ene
is unknown.
In  the present study, we demonstrated the efﬁcacy of 3-
estearioxy-olean-12-ene, a triterpene isolated from the roots of A.
brachypoda, in different anti-inﬂammatory tests. Thus, it may  be
useful in the treatment of inﬂammatory disorders, which supports
previous claims of its traditional use.
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